Stockscreener 앱 받기
0.102
43.30%
-0.0779
Imac Holdings Inc 주식(BACK)의 최신 뉴스
IMAC Holdings Secures Promissory Note for Financial Stability - TipRanks
IMAC (NASDAQ:BACK) Stock Price Up 32.1% – Time to Buy? - Defense World
IMAC Holdings Issues Secured Promissory Note - MSN
IMAC Holdings (BACK) issues $245,000 secured note maturing February 2026 - Stock Titan
IMAC Holdings, Inc. announced that it has received $0.175 million in funding - marketscreener.com
IMAC Holdings Delays Q3 10-Q Filing - MSN
[NT 10-Q] IMAC Holdings, Inc. SEC Filing - Stock Titan
IMAC Holdings, Inc. announced that it has received $0.15 million in funding - MarketScreener
Total debt per share of IMAC Holdings, Inc. – OTC:BACK - TradingView
Total debt per share of IMAC Holdings, Inc. – SWB:I020 - TradingView
IMAC Holdings Issues Promissory Note for Liquidity - MSN
[8-K] IMAC Holdings, Inc. Reports Material Event | BACK SEC FilingForm 8-K - Stock Titan
IMAC Holdings, Inc. announced that it has received $0.204 million in funding - MarketScreener
Imac Holdings Inc (BACK) Insider Trade Summaries - The Globe and Mail
Imac Holdings Inc (BACK) Statistics - The Globe and Mail
Imac Holdings Inc (BACK) Profile - The Globe and Mail
Imac Holdings Inc (BACK) Performance - The Globe and Mail
IMAC Holdings Issues Unsecured Promissory Note - MSN
IMAC (BACK) raises $144,000 via unsecured $201,600 note - Stock Titan
IMAC Holdings, Inc. announced that it has received $0.144 million in funding - MarketScreener
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IMAC Holdings, Inc. Merger - 富途牛牛
IMAC Holdings, Inc. announced that it has received $0.212 million in funding - MarketScreener
IMAC Holdings Issues Promissory Note Amid Board Changes - TipRanks
Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers - GlobeNewswire
600 Late-Stage Cancer Patients: Ignite Proteomics Launches Groundbreaking Precision Treatment Study - Stock Titan
IMAC Holdings Announces Research Collaboration with - GlobeNewswire
Cancer Research Breakthrough: IMAC-Vanderbilt Alliance Targets New Breast Cancer Treatment Markers - Stock Titan
IMAC Holdings Announces Research Collaboration with Vanderbilt U - GuruFocus
IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery - Yahoo Finance
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
Nasdaq Announces Delisting of Multiple Companies Including NKGen Biotech, Aquaron Acquisition Corp, and Others - Quiver Quantitative
Allarity Therapeutics appoints Jeffrey S. Ervin as part-time chief financial officer - Investing.com Nigeria
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - The Manila Times
Former NYSE Executive Takes CFO Role at Cancer Drug Developer Allarity Therapeutics - Stock Titan
Imac Holdings Issues Unsecured Promissory Note - TipRanks
Form 10-KAnnual Reports - Stock Titan
BACK SEC FilingsImac Hldgs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Is IMAC Holdings, Inc. overvalued or undervalued? - MarketsMojo
HCA Healthcare (HCA) Stock Drops 5% Amid Industry Decline - GuruFocus
IMAC Holdings, Inc. (IMAC) Competitors - Meyka
1.82%
0.39%
자본화:
|
볼륨(24시간):